Docklight Brands Inc v. Tilray Inc

District Court, W.D. Washington·Decided August 14, 2023·No. 2:21-cv-01692·Unknown

Opinion

1 2 3 WESTERN DISTRICT OF WASHINGTON 6 DOCKLIGHT BRANDS INC, 7 Plaintiff-Counterclaim Defendant, CASE NO. 2:21-cv-01692-TL 8 v. ORDER GRANTING DEFENDANTS’ MOTION TO 9 TILRAY INC. and HIGH PARK COMPEL (DKT. 210/212) HOLDINGS LTD, 10 Defendants-Counterclaimants. 11

On July 31, 2023, the parties filed a joint LCR 37 Submission Regarding Plaintiff’s 12 Responses to Defendants’ Discovery Requests. Dkts. 210 and 213 (sealed at Dkts. 212 and 214). 13 Defendants’ motion to compel is granted. 14 BACKGROUND 15 Docklight’s Third Amended Complaint alleges Defendants’ failure to exercise 16 commercially reasonable efforts and nonpayment under its sublicense (the “High Park License”) 17 caused the Marley Estate to terminate Docklight’s worldwide license to develop and sell Marley- 18 branded products (the “Marley License”). Dkt. 163 ¶ 4.23. In addition to the $13.7 million 19 Docklight seeks for Defendants’ alleged breaches of the High Park License, Docklight asserts 20 $125 million for loss of the Marley License worldwide, due to purported lost profits through 21 2044. Id., Ex. C at 3. 22 Defendants seek two categories of documents: (1) documents reflecting Docklight’s other 23 sublicensees’ efforts and success in commercializing the brands (which include sales outside of 1 Canada); and (2) documents regarding Docklight and Marley’s compliance with the Marley 2 License’s commercialization provisions. For the first category of documents, Defendants’ 3 requests are limited to the same categories of documents Docklight asked them to produce 4 regarding their commercialization efforts under the High Park License. For both categories,

5 Defendants contend their requests are rooted in already-produced discovery suggesting more 6 documents exist to support Defendants’ defenses against Docklight’s $125 million claimed 7 damages. According to Defendants, documents produced to date indicate Docklight breached 8 multiple provisions of the Marley License and that Docklight, Marley, and Docklight’s other 9 eight sublicensees failed to commercialize the brands. 10 Docklight objects to producing “a slew” of documents pertaining to details of the 11 performance of licenses with other parties under which Docklight earned revenues from the 12 Marley brand outside Canada because “this Court has previously recognized that the 13 performance of contracts other than the one at issue in this case is generally “irrelevant” and non- 14 discoverable.” Dkt. 210 at 5-6. Docklight argues the sales information sought by Defendants is

15 not relevant to: (1) “benchmarking” Defendants’ performance (or excusing their non- 16 performance) in manufacturing, marketing, and selling inhalable THC products in Canada; (2) an 17 analysis of the revenues Docklight would have earned had it not lost the Marley rights; (3) 18 whether Defendants’ decision to cut off 60% of Docklight’s revenues in October 2021 caused 19 Docklight to lose the Marley rights; and (4) whether Docklight adequately attempted to mitigate 20 damages for its loss of a licensee in Canada. Docklight contends the only information needed to 21 evaluate its claim for loss of revenues are “documents reflecting historical sales, forecasts, plans, 22 and projections in every market in which Docklight earned revenues from the Marley brand.” 23 Dkt. 210 at 5. 1 Docklight also objects to producing documents pertaining to its performance under the 2 Marley License, other than its obligation to pay a guaranteed minimum royalty (“GMR”). 3 Docklight argues these requests are based on mere speculation that Docklight may have breached 4 other obligations under the Marley License. Dkt. 210 at 6-7.

6 “Parties may obtain discovery regarding any nonprivileged matter that is relevant to any 7 party's claim or defense and proportional to the needs of the case.” Fed. R. Civ. P. 26(b)(1). 8 Under Rule 26, the concept of relevance “has been construed broadly to encompass any matter 9 that bears on, or that reasonably could lead to other matter that could bear on, any issue that is or 10 may be in the case.” Oppenheimer Fund, Inc. v. Sanders, 437 U.S. 340, 351 (1978). When 11 determining whether evidence is discoverable, the Court must also consider “whether the burden 12 or expense of the proposed discovery outweighs its likely benefits.” Fed. R. Civ. P. 26(b)(1). 13 Once the party seeking discovery has established the request meets this relevancy requirement, 14 “the party opposing discovery has the burden of showing that the discovery should be prohibited,

15 and the burden of clarifying, explaining or supporting its objections.” Bryant v. Ochoa, 2009 WL 16 1390794, at *1 (S.D. Cal. May 14, 2009). 17 A. Documents Regarding Non-Canada Sublicensees 18 Defendants’ RFPs 58-63, 76-77, 84, 106, 107, and 152 seek information regarding the 19 efforts Docklight and its sublicensees made to maximize sales. Dkt. 213, Exs. A, B, H. Docklight 20 objects that Defendants’ demand is not relevant as to non-competing products (all licensed 21 products sold in Canada were inhalable THC-dominant products while a majority of licensed 22 products sold outside Canada were from cannabis accessories containing no THC and CBD 23 products with almost no THC). 1 As the Court previously recognized, “Docklight’s [Third Amended Complaint] expands 2 the scope of relevant discovery … to worldwide,” and “make[s] the performance of Docklight’s 3 international sublicensees relevant.” Dkt. 201 at 4. The Court extended the trial date and pretrial 4 deadlines to allow Defendants to complete discovery into the “sales, marketing, expenses, and

5 financials” of Docklight and its third-party sublicensees world-wide…. Id. In addition, the Court 6 agrees the documents are relevant as a baseline for commercial reasonableness, future lost 7 income, causation, and mitigation. 8 1. Baseline for Commercial Reasonableness 9 Docklight disagrees documents relating to the commercial efforts of its sublicensees are 10 relevant to whether Defendants acted in a commercially reasonable manner because Docklight’s 11 other licenses covered different markets (outside of Canada) and different sales (non-inhalable 12 THC products). Docklight first raised the issue of Defendants’ lack of commercially reasonable 13 efforts in its termination notice. Dkt. 213, Ex. F. In response, Defendants point to their sales, 14 which exceeded all eight of Docklight’s other sublicensees combined (Dkt. 183 ¶ 2 (Defendants’

15 sales over 60% of Docklight revenue)) and a March 2020 valuation (issued before Defendants’ 16 breaches), in which Docklight projected it would lose $35 million between 2020 and 2025, 17 becoming profitable only in 2026. Id., Ex. L at DOCK051182 (line 6: Net income/loss). 18 While the licensees were operating in different markets and Defendants were operating in 19 Canada, where recreational cannabis is legalized nationwide, the Court agrees the information 20 sought is broadly relevant to establishing a baseline – or at least a basis for deriving a baseline 21 measurement to which Defendants’ results might be compared. See, e.g., Plexicoat America LLC 22 v. PPG Architectural Finishes, Inc, 2015 WL 171831, at *3, n.6. Information about Docklight’s 23 other sublicensees’ efforts may also be relevant to Docklight’s expectations about what 1 constitutes commercially reasonable efforts. See Warner Bros. Int’l Television Dist. v. Golden 2 Channels & Co., 2003 WL 27384420, at *5 (C.D. Cal. Sept. 26, 2003) (granting motion to 3 compel where information could demonstrate licensor’s expectations about licensee’s 4 performance).

Free access — add to your briefcase to read the full text and ask questions with AI

Docklight Brands Inc v. Tilray Inc, (W.D. Wash. 2023).

Docklight Brands Inc v. Tilray Inc (Docklight Brands Inc v. Tilray Inc) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Oppenheimer Fund, Inc. v. Sanders
437 U.S. 340 (Supreme Court, 1978)